We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
Parallel™ is the first prescription only digital therapeutic to provide cognitive behavioural therapy (CBT) to adults with irritable bowel syndrome (IBS) to receive the FDA Marketing Authorization in the US. ParallelTM has also obtained a CE mark and been recommended for Evaluation in Practice by the National Institute for Health and Care Excellence (NICE).
By NIHR Maudsley BRC at 1 Apr 2021
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
